Recognized gain on sale of investment securities of 15,485 million yen. Of that amount, 6,061 million yen will be recorded in the consolidated accounting period for Q1 of the fiscal year ending March 2027. The sale was conducted as part of corporate governance measures to reduce policy holdings. For future impact, refer to the Notice of Revision of Full-Year Consolidated Earnings Forecasts.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7459","jir_company_name":"MediPal Holdings Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-23","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/7459-20261023-01.pdf","jir_short_summary":"Recognized gain on sale of investment securities of 15,485 million yen. Of that amount, 6,061 million yen will be recorded in the consolidated accounting period for Q1 of the fiscal year ending March 2027. The sale was conducted as part of corporate governance measures to reduce policy holdings. For future impact, refer to the Notice of Revision of Full-Year Consolidated Earnings Forecasts.","jir_summary":"### Key Points of the News\nMediPal Holdings Corporation recognized a gain on sale of investment securities totaling 15,485 million yen due to the sale and reduction of some of its held investment securities. Of this, 6,061 million yen is scheduled to be recorded in the consolidated accounting period for Q1 of the fiscal year ending March 2027. The sales are part of measures to strengthen corporate governance and achieve management mindful of capital costs and share price. For future impacts, refer to the Notice of Revision of Full-Year Consolidated Earnings Forecasts.\n\n### Outlook and Impact\nThe extent to which this gain will affect full-year results is detailed in the Notice of Revision of Full-Year Consolidated Earnings Forecasts published on the same day. The gain is recorded as extraordinary income and may influence future financial indicators and shareholder return policies.","jir_financial_highlights":"Gain on Sale of Investment Securities (Extraordinary Income): 15,485 million yen (Unknown)\nOf which recorded in Q1 of FY ending March 2027: 6,061 million yen (Unknown)","jir_category":"","jir_hashtags":"#MediPalHoldingsInvestmentSecuritiesGain, #ExtraordinaryIncome, #NoCapitalPolicyRelatedActionRequired","jir_key_figures":"Gain on Sale of Investment Securities (Extraordinary Income): 15,485 million yen\nOf which recorded in Q1 of FY ending March 2027: 6,061 million yen\nSale period: May 2026\uff5eOctober 2026","jir_meta_title":"MediPal Holdings Corporation Announces Recognition of Gain on Sale of Investment Securities\uff5cOctober 2026","jir_meta_description":"MediPal Holdings Corporation has recognized a gain on sale of investment securities totaling 15,485 million yen, reporting the breakdown and the expected portion to be recorded in Q1 of the fiscal year ending March 2027. A revision to the full-year earnings forecast will be announced.","jir_og_title":"MediPal Holdings Corporation Recognizes Gain on Sale of Investment Securities\uff5cOctober 2026","jir_og_description":"MediPal Holdings Corporation recorded a gain on sale of investment securities as extraordinary income. Refer to the revision of the full-year earnings forecast for future impact.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7774,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-133874","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n